RA
IDXG

Royce & Associates’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Royce & Associates’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-654
Closed -$117K – 1318
2014
Q4 		$117K Sell
654
-5,654
-90% -$1.01M ﹤0.01% 1214
2014
Q3 		$1.51M Sell
6,308
-1,798
-22% -$601K 0.01% 1056
2014
Q2 		$3.55M Sell
8,106
-745
-8% -$344K 0.01% 935
2014
Q1 		$4.05M Hold
8,851
– – 0.01% 929
2013
Q4 		$4.26M Hold
8,851
– – 0.01% 906
2013
Q3 		$4.27M Sell
8,851
-2,256
-20% -$1.08M 0.01% 889
2013
Q2 		$5.22M Buy
+11,107
New +$5.04M 0.02% 834

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.69B AUM 19.05% 1-Year Est. Return
LCM
Leonard Capital Management Vero Beach, Florida $5.25M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return